论文信息 - The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region

The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region

Monoclonal antibody (MAb) treatments have been safe and effective in averting severe Covid-19 infections when given early, but supplies have been scarce. Intermountain Healthcare used its supply to maximum effect across its broad geographic footprint by identifying patients at highest risk and delivering them MAb therapy at the optimal time, saving lives and easing strain on hospitals.

[1] Samuel M. Brown,et al. Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19 , 2021, Open forum infectious diseases.

[2] J. Bledsoe,et al. Simple scoring tool to estimate risk of hospitalization and mortality in ambulatory and emergency department patients with COVID-19 , 2021, medRxiv.

[3] D. Skovronsky,et al. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 , 2020, The New England journal of medicine.

[4] R. Srivastava,et al. Rapid Implementation of a Complex, Multimodal Technology Response to COVID-19 at an Integrated Community-Based Health Care System , 2020, Applied Clinical Informatics.

[5] Samuel M. Brown,et al. How Community-Based Health Systems Embrace Research During the COVID-19 Pandemic , 2020, Quality management in health care.